1. Home
  2. BCAL vs PRTC Comparison

BCAL vs PRTC Comparison

Compare BCAL & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAL
  • PRTC
  • Stock Information
  • Founded
  • BCAL 2001
  • PRTC 2015
  • Country
  • BCAL United States
  • PRTC United States
  • Employees
  • BCAL N/A
  • PRTC N/A
  • Industry
  • BCAL Major Banks
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BCAL Finance
  • PRTC Health Care
  • Exchange
  • BCAL Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • BCAL 478.1M
  • PRTC 432.3M
  • IPO Year
  • BCAL N/A
  • PRTC N/A
  • Fundamental
  • Price
  • BCAL $14.76
  • PRTC $18.70
  • Analyst Decision
  • BCAL Strong Buy
  • PRTC Buy
  • Analyst Count
  • BCAL 1
  • PRTC 1
  • Target Price
  • BCAL $20.00
  • PRTC $45.00
  • AVG Volume (30 Days)
  • BCAL 76.1K
  • PRTC 3.3K
  • Earning Date
  • BCAL 07-28-2025
  • PRTC 04-30-2025
  • Dividend Yield
  • BCAL N/A
  • PRTC N/A
  • EPS Growth
  • BCAL N/A
  • PRTC N/A
  • EPS
  • BCAL 0.62
  • PRTC 0.21
  • Revenue
  • BCAL $132,045,000.00
  • PRTC $4,828,000.00
  • Revenue This Year
  • BCAL $74.16
  • PRTC $35.98
  • Revenue Next Year
  • BCAL $4.92
  • PRTC $115.38
  • P/E Ratio
  • BCAL $23.62
  • PRTC $8.39
  • Revenue Growth
  • BCAL 42.63
  • PRTC 44.98
  • 52 Week Low
  • BCAL $11.87
  • PRTC $13.30
  • 52 Week High
  • BCAL $18.49
  • PRTC $31.00
  • Technical
  • Relative Strength Index (RSI)
  • BCAL 53.48
  • PRTC 59.67
  • Support Level
  • BCAL $14.50
  • PRTC $17.80
  • Resistance Level
  • BCAL $15.27
  • PRTC $19.17
  • Average True Range (ATR)
  • BCAL 0.46
  • PRTC 0.50
  • MACD
  • BCAL -0.06
  • PRTC 0.13
  • Stochastic Oscillator
  • BCAL 31.53
  • PRTC 82.26

About BCAL Southern California Bancorp

California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: